New developments in non-specific and semi-specific immunosuppression in type I diabetes

Diabetes Metab Rev. 1993 Dec;9(4):257-67. doi: 10.1002/dmr.5610090406.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antilymphocyte Serum / pharmacology
  • Cyclosporine / therapeutic use
  • Diabetes Mellitus, Experimental / immunology
  • Diabetes Mellitus, Experimental / prevention & control
  • Diabetes Mellitus, Experimental / therapy
  • Diabetes Mellitus, Type 1 / immunology
  • Diabetes Mellitus, Type 1 / prevention & control*
  • Diabetes Mellitus, Type 1 / therapy
  • Humans
  • Immunosuppression Therapy / methods*
  • Immunosuppressive Agents / administration & dosage
  • Insulin / administration & dosage
  • Lymphokines / antagonists & inhibitors
  • Photopheresis
  • Prediabetic State / immunology
  • Prediabetic State / prevention & control
  • Prediabetic State / therapy

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Insulin
  • Lymphokines
  • Cyclosporine